ProText Mobility (ProText Mobility) Risk Assessment

View and export this data going back to 2003. Start your Free Trial

What is ProText Mobility Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of ProText Mobility is: No Data: Cannot be evaluated.

Competitive Comparison of ProText Mobility's Risk Assessment

For the Biotechnology subindustry, ProText Mobility's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ProText Mobility's Risk Assessment Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ProText Mobility's Risk Assessment distribution charts can be found below:

* The bar in red indicates where ProText Mobility's Risk Assessment falls into.

ProText Mobility (OTCPK:TXTM) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

ProText Mobility Risk Assessment Related Terms

Thank you for viewing the detailed overview of ProText Mobility's Risk Assessment provided by GuruFocus.com. Please click on the following links to see related term pages.

ProText Mobility (ProText Mobility) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProText Mobility Inc (OTCPK:TXTM) » Definitions » Risk Assessment

Comparable Companies

Traded in Other Exchanges

N/A

Address

One West Las Olas Boulevard, Suite 500, Fort Lauderdale, FL, USA, 33301

Website

https://www.protxtm.com

ProText Mobility Inc is a Biotech Company developing a Hemp/CBD - Cannabis medicines platform for the legal cannabis industry, using proprietary live plant extraction processes & technologies. Protext has engaged in the research, testing, and development of bioavailable botanical products all-natural ingredients formulated for nutraceuticals and pharmaceutical applications through proprietary live plant extraction technology.

Executives

Peter Sealey

director

37400 CENTRAL COURT, NEWARK CA 94560